Company news
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) news
Sun Pharmaceutical Industries Limited news releases on 6ix. Latest, Oct 6, 2026: Sun Pharma Establishes Endowed Professorship at Mount Sinai to Advance…
Press releases & updates
Sun Pharma Establishes Endowed Professorship at Mount Sinai to Advance Dermatologic Care
October 6, 2026
New LEQSELVI® (deuruxolitinib) Two-Year Data in Severe Alopecia Areata Showed Sustained Efficacy and Safety at EADV Congress 2026
October 1, 2026
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 01, 2026, titled "New LEQSELVI® (deuruxolitinib) Two-YearData in Severe Alopecia Areata Showed Sustained Efficacy and Safety at EADV Congress 2026".
October 1, 2026
LIB Therapeutics and Sun Pharma Announce Global Licensing, Commercialization and Manufacturing Agreement for Lerodalcibep, a Novel PCSK9 Inhibitor, Ex-US and China; Lerodalcibep (Lyrokaul®) Approved in the EU
September 28, 2026
Sun Pharmaceutical Industries Limited Press Release Sep 28 2026
September 27, 2026
Sun Pharma Launches (C)Taro-Methylphenidate ER, the First and Only Bioequivalent to Concerta® with an Osmotic Delivery System
September 24, 2026
First-Ever Standardized U.S. Treatment Recommendations Issued for Adults with Severe Alopecia Areata; Sun Pharma Welcomes Milestone
September 22, 2026
Sun Pharma and Christian Siriano Launch "Regrowth Restyled" to Inspire Adults Living with Severe Alopecia Areata
September 17, 2026
Sun Pharmaceutical Industries Limited Press Release Sep 01 2026
August 31, 2026
Sun Pharmaceutical Industries Limited Press Release Jul 29 2026
July 29, 2026
Sun Pharmaceutical Industries Limited Press Release Jul 24 2026
July 23, 2026
Sun Pharmaceutical Industries Limited Press Release Jul 15 2026
July 14, 2026
AMERICAN SKIN ASSOCIATION ANNUAL GALA RECOGNIZES SUN PHARMA WITH CORPORATE LEADERSHIP AWARD
June 3, 2026
At the ASCO® 2026 Annual Meeting, Sun Pharma to Present Pivotal Long-Term Follow-up Data on UNLOXCYT™ (cosibelimab-ipdl)
May 26, 2026
Press Release May 26 2026
May 26, 2026
Sun Pharmaceutical Industries, Inc. (Sun Pharma) Initiates Voluntary U.S. Nationwide Recall of DOXOrubicin Hydrochloride Liposome ...
May 13, 2026
Sun Pharma To Acquire Organon
May 8, 2026
Organon Cancels First Quarter Earnings Call
April 29, 2026
Press Release Apr 27 2026
April 27, 2026
Sun Pharma signs Definitive Agreement to Acquire Organon
April 26, 2026
Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million
March 30, 2026
Press Release Mar 27 2026
March 27, 2026
Press Release Mar 21 2026
March 21, 2026
Press Release Mar 16 2026
March 16, 2026
Sun Pharma Announces US FDA Acceptance of Supplemental Biologics License (sBLA) Application for ILUMYA® (tildrakizumab-asmn) for the Treatment of Adults with Active Psoriatic Arthritis
March 16, 2026
Sun Pharma Showcases Data Across its Dermatology & Immunology Portfolio at 2026 Winter Clinical Miami
February 27, 2026
U.S. Patent Office Issues Final Written Decision Finding All Challenged Claims of Sun Pharma’s Patent 11,697,028 To Be Unpatentable
February 26, 2026
Sun Pharma Introduces SUNday, Highlighting the Everyday Realities of Skin Cancer Care
February 5, 2026
Press Release Jan 23 2026
January 23, 2026
Sun Pharmaceutical Industries Limited Press Release Jan 23 2026
January 22, 2026
Sun Pharma Announces the Availability of UNLOXCYT for Advanced Cutaneous Squamous Cell Carcinoma
January 16, 2026
Press Release Jan 15 2026
January 15, 2026
Sun Pharma Announces the Availability of UNLOXCYT™ (cosibelimab-ipdl) for Advanced Cutaneous Squamous Cell Carcinoma (aCSCC)
January 15, 2026
ILUMYA® (tildrakizumab) Pen (Auto-Injector) Now Available for Canadians Living with Moderate-to-Severe Plaque Psoriasis
January 7, 2026
Sun Pharma Launches ILUMYA® In India
January 2, 2026
Press Release Dec 01 2025
December 1, 2025
Sun Pharmaceutical Industries Limited Press Release Dec 01 2025
November 30, 2025
Press Release Nov 26 2025
November 26, 2025
FDA approves label update for UNLOXCYT™ (cosibelimab-ipdl) based on longer-term data that demonstrated improved clinical outcomes in advanced cutaneous squamous cell carcinoma (aCSCC)
November 24, 2025
Press Release Nov 17 2025
November 17, 2025
Press Release Nov 12 2025
November 12, 2025
Sun Pharma Canada Inc. Acquires Commercial Rights to LEVULAN® KERASTICK®
November 12, 2025
Sun Pharmaceutical Industries Limited Press Release Nov 12 2025
November 11, 2025
Sun Pharma Announces Jeremy Allen as Vice President, Corporate Affairs for North America
October 22, 2025
Mallinckrodt Names Dr. Marek J. Honczarenko as EVP and Chief Scientific Officer
September 22, 2025
Press Release Jul 21 2025
July 21, 2025
Sun Pharmaceutical Industries Limited Press Release Jul 21 2025
July 20, 2025
Sun Pharma Announces Appointment of Richard Ascroft as CEO North America
June 25, 2025
Press Release Jun 24 2025
June 24, 2025
Sun Pharma appoints Kirti Ganorkar as the Managing Director, Dilip Shanghvi to continue as the Executive Chairman of the Board
June 16, 2025